Related Experiment Video
Updated: Jun 25, 2026
11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Type 1 and Type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease?
1University of Washington, Department of Urology, Seattle, WA 98109, USA. kanchanc@u.washington.edu
The Journal of Sexual Medicine
|March 10, 2009
Summary
Erectile dysfunction (ED) mechanisms differ between type 1 and type 2 diabetes in animal models. Understanding these differences is key for developing targeted treatments for diabetic ED.
Area of Science:
- Urology
- Endocrinology
- Diabetology
Background:
- Hyperglycemia is common in both type 1 and type 2 diabetes, but distinct characteristics differentiate them.
- Erectile dysfunction (ED) is a known complication in animal models of both diabetes types.
Purpose of the Study:
- To investigate unique mechanisms underlying ED in type 1 versus type 2 diabetic animal models.
- To compare the specific pathways contributing to ED in different diabetes models.
Main Methods:
- Literature review of PubMed database.
- Evaluation of known mechanisms causing ED in type 1 and type 2 diabetic animal models.
- Analysis of impaired dilatory signaling, contractile sensitivity, and veno-occlusive disorder.
Main Results:
- Type 1 diabetic rodents show impaired cavernosal vasodilation due to nerve signaling defects and endothelial dysfunction.
- Type 2 diabetic models exhibit endothelial dysfunction with minimal parasympathetic impairment but increased cavernosal contractile sensitivity and veno-occlusive disorder.
Conclusions:
- Distinct mechanisms for ED in type 1 and type 2 diabetes warrant tailored therapeutic strategies.
- Further research in human patients may refine the diagnosis and treatment of diabetic ED.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...